3Murphy S, Peterson P, Iland H,et al. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria,survival, and leukemia transition by treatment[J].Semin Hematol,1997,34(1):29-39.
二级参考文献5
1Murphy S, Peterson P,Iland H, et al. Experience of the Polycythemia Vera StudyGroup with essential thrombocythemia：a final report on diagnostic criteria,survival,andleukemic transition by treatment .Semin Hematol,1997,34：29～39
2Basses C, Cervantes F, Pereira A, et al. Major vascular complications in essentialthrombocythemia：a study of the predictive factors in a series of 148 patients.Leukemia,1999,13：150～154
3Sterkers Y, Preudhomme C,Lai JL, et al. Acute myeloid leukemia and myelodysplasticsyndromes following essential thrombocythaemia treated with hydroxyura：high proportionof cases with 17p deletion. Blood,1998,91：616～622
4Barbui T, Finazzi G, Dupuy E, et al. Treatment strategies in essentialthrombocythemia：a critical appraisal of various experiences in different centers.Leukemia and Lymphoma,1996,22(Suppl 1)：149～160
收稿 1999-03-30
修回 1999-09-10
2Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with disease [J]. Blood, 2001,97(11):6628-3632
3Steinberg M H, Barton F, Castro O,et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment [J].JAMA ,2003,289 (13) : 1645-1651
4Hoppe C, Vichinsky E, Quirolo K,et al. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease[J]. J Pediatr Hematol Oncol,2000,22(4) :330-334
5Arruda VR, Lima CS, Saad St, et al. Successful use of hydroxyurea in beta-thalassemia major[J]. N Engl J Med, 1997,336(13) :964
6Kumar B ,Saraswat A , Kaur I. Rediscovering hydroxyurea: its role in recalcitrant psoriasis[J] . Invt J Dermatol, 2001,40(8) :530-534
7Fruchtman SM, Mack K, Kaplan ME, et al. From efficacy to safty ,apolycythemia vera study group report on hydroxyurea in patients with polycythemia vera[J].Semin Hematol, 1997,34:17-21
8Piccinini G, Foli A, Comolli G, et al. Complementary antiviral efficacy of hydroxyurea and protease inhibitors in human immunodeficiency virus - infected dendritic cells and lymphocytes [J]. J Virol. 2002,76 (5) :2274-2278
9Lori F,Jessen H ,Lieberman D,et al. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir[J]. J Infect. Dis,1999,180:1827-1832
